Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FIGO Stage IVA Cervix Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00287911
What this trial is testing

Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Masonic Cancer Center, University of Minnesota 18
Early research (Phase 1)WithdrawnNCT00428194
What this trial is testing

Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer

Who this might be right for
Cervical Cancer
Masonic Cancer Center, University of Minnesota
Large-scale testing (Phase 3)Looking for participantsNCT07061977
What this trial is testing

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Who this might be right for
Locally Advanced Cervical AdenocarcinomaLocally Advanced Cervical Adenosquamous CarcinomaLocally Advanced Cervical Squamous Cell Carcinoma+5 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00082823
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)UnknownNCT01295502
What this trial is testing

Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+6 more
Gynecologic Oncology Group 45
Not applicableStudy completedNCT00004936
What this trial is testing

MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients

Who this might be right for
Cervical Cancer
American College of Radiology Imaging Network
Testing effectiveness (Phase 2)Study completedNCT00101192
What this trial is testing

Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 76
Early research (Phase 1)Study completedNCT00287885
What this trial is testing

Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+5 more
Masonic Cancer Center, University of Minnesota 18
Testing effectiveness (Phase 2)WithdrawnNCT00452920
What this trial is testing

Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer

Who this might be right for
Cervical Cancer
University of Miami
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)Study completedNCT00941070
What this trial is testing

Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer

Who this might be right for
Recurrent Cervical CancerRecurrent Vaginal CancerStage IB Cervical Cancer+10 more
National Cancer Institute (NCI) 26
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00098995
What this trial is testing

Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Who this might be right for
Cervical Cancer
Peter MacCallum Cancer Centre, Australia 22
Not applicableLooking for participantsNCT05947513
What this trial is testing

Concomitant Curcumin Palliative Radiotherapy in Advanced Cervical Cancer Trial

Who this might be right for
Cervical Cancer
Addis Ababa University 27
Testing effectiveness (Phase 2)Study completedNCT00087113
What this trial is testing

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Early research (Phase 1)Looking for participantsNCT03968406
What this trial is testing

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Who this might be right for
Malignant Female Reproductive System NeoplasmRecurrent Cervical CarcinomaRecurrent Endometrial Carcinoma+22 more
M.D. Anderson Cancer Center 24
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Active Not RecruitingNCT02595879
What this trial is testing

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

Who this might be right for
Advanced Cervical AdenocarcinomaAdvanced Cervical Adenosquamous CarcinomaAdvanced Cervical Squamous Cell Carcinoma+10 more
National Cancer Institute (NCI) 21
Early research (Phase 1)Study completedNCT03738228
What this trial is testing

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+8 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT03634267
What this trial is testing

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus-Related Cervical CarcinomaStage IB2 Cervical Cancer AJCC v8+14 more
M.D. Anderson Cancer Center 26
Next Page
336